Anti-inflammatory and anti-coagulatory activities of caffeic acid and ellagic acid in cardiac tissue of diabetic mice.
BACKGROUND
Caffeic acid (CA) and ellagic acid (EA) are phenolic acids naturally occurring in many plant foods. Cardiac protective effects of these compounds against dyslipidemia, hypercoagulability, oxidative stress and inflammation in diabetic mice were examined.


METHODS
Diabetic mice were divided into three groups (15 mice per group): diabetic mice with normal diet, 2% CA treatment, or 2% EA treatment. One group of non-diabetic mice with normal diet was used for comparison. After 12 weeks supplement, mice were sacrificed, and the variation of biomarkers for hypercoagulability, oxidative stress and inflammation in cardiac tissue of diabetic mice were measured.


RESULTS
The intake of CA or EA significantly increased cardiac content of these compounds, alleviated body weight loss, elevated plasma insulin and decreased plasma glucose levels in diabetic mice (p < 0.05). These treatments also significantly enhanced plasma antithrombin-III and protein C activities (p < 0.05); and decreased triglyceride content in cardiac tissue and plasma (p < 0.05), in which the hypolipidemic effects of EA were significantly greater than that of CA (p < 0.05). CA or EA significantly lowered cardiac levels of malondialdehyde, reactive oxygen species, interleukin (IL)-beta, IL-6, tumor necrosis factor (TNF)-alpha and monocyte chemoattractant protein (MCP)-1 (p < 0.05); and retained cardiac activity of glutathione peroxidase (GPX), superoxide dismutase (SOD) and catalase (p < 0.05). These compounds also significantly up-regulated cardiac mRNA expression of GPX1, SOD and catalase; and down-regulated IL-1beta, IL-6, TNF-alpha and MCP-1 mRNA expression in diabetic mice (p < 0.05).


CONCLUSIONS
These results support that CA and EA could provide triglyceride-lowering, anti-coagulatory, anti-oxidative, and anti-inflammatory protection in cardiac tissue of diabetic mice. Thus, the supplement of these agents might be helpful for the prevention or attenuation of diabetic cardiomyopathy.
Chao
Pei-Chun
PC
Department of Nutrition, China Medical University, Taichung City, Taiwan, Republic of China. cshc029@csh.org.tw
Hsu
Cheng-Chin
CC
Yin
Mei-Chin
MC
Clin Chem. 1975 Mar;21(3):437-41
1112059
Photochem Photobiol. 2006 Nov-Dec;82(6):1668-76
16836471
Semin Thromb Hemost. 2000;26(1):39-42
10805280
Free Radic Biol Med. 1997;22(4):593-6
9013122
Anticancer Res. 2006 Sep-Oct;26(5A):3601-6
17094489
J Intern Med. 2001 Nov;250(5):415-21
11887976
Coron Artery Dis. 2005 Nov;16 Suppl 1:S3-S10
16340402
Cardiovasc Res. 2009 Feb 15;81(3):457-64
19047340
J Am Coll Cardiol. 2008 Aug 19;52(8):655-66
18702970
Hypertension. 2001 Apr;37(4):1053-9
11304502
Food Chem Toxicol. 2007 Oct;45(10):1899-909
17560706
J Lipid Res. 1973 May;14(3):364-6
14580182
Diabetes Res Clin Pract. 2000 Jul;49(1):23-31
10808060
Endocr Regul. 2008 Sep;42(4):129-35
18999900
Diabet Med. 2003 Nov;20(11):930-4
14632719
J Pharmacol Exp Ther. 2006 Aug;318(2):476-83
16644902
J Biol Chem. 2003 Nov 21;278(47):46654-60
13129912
Diabetes. 2004 May;53(5):1336-43
15111504
Eur J Clin Invest. 2000 Nov;30(11):995-1001
11114962
Thromb Haemost. 1997 Sep;78(3):1030-6
9308749
J Agric Food Chem. 2002 Jun 19;50(13):3660-7
12059140
Horm Metab Res. 2003 Apr;35(4):251-8
12778369
J Cardiovasc Pharmacol. 2008 Aug;52(2):136-44
18670366
Int J Food Sci Nutr. 2007 Feb;58(1):18-28
17415953
Food Chem Toxicol. 2008 Mar;46(3):1119-24
18155344
J Agric Food Chem. 2002 Apr 10;50(8):2432-8
11929309
Circ J. 2005 Dec;69(12):1484-9
16308496
Hypertension. 2003 Aug;42(2):206-12
12847113
J Biol Chem. 1951 Nov;193(1):265-75
14907713